These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 33557738)
1. Preclinical Studies and Clinical Trials with Mesenchymal Stem Cell for Demyelinating Diseases: A Systematic Review. Esmaeilizade Z; Mohammadi B; Omrani MD; Ghaderian SMH; Rajabibazl M; Fazeli Z Curr Stem Cell Res Ther; 2021; 16(8):1005-1017. PubMed ID: 33557738 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells in experimental autoimmune encephalomyelitis model of multiple sclerosis: A systematic review and meta-analysis. Yanwu Y; Meiling G; Yunxia Z; Qiukui H; Birong D Mult Scler Relat Disord; 2020 Sep; 44():102200. PubMed ID: 32535500 [TBL] [Abstract][Full Text] [Related]
3. The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS). Al Jumah MA; Abumaree MH Int J Mol Sci; 2012; 13(7):9298-9331. PubMed ID: 22942767 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors. Kassis I; Petrou P; Halimi M; Karussis D Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102 [TBL] [Abstract][Full Text] [Related]
6. The Efficacy of Mesenchymal Stem Cell Therapies in Rodent Models of Multiple Sclerosis: An Updated Systematic Review and Meta-Analysis. He J; Huang Y; Liu J; Lan Z; Tang X; Hu Z Front Immunol; 2021; 12():711362. PubMed ID: 34512632 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies. Gugliandolo A; Bramanti P; Mazzon E Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212873 [TBL] [Abstract][Full Text] [Related]
8. Effects of mesenchymal stem cells transplantation on multiple sclerosis patients. Barati S; Tahmasebi F; Faghihi F Neuropeptides; 2020 Dec; 84():102095. PubMed ID: 33059244 [TBL] [Abstract][Full Text] [Related]
9. The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS-A Review Focusing on Neuroprotective Properties. Gavasso S; Kråkenes T; Olsen H; Evjenth EC; Ytterdal M; Haugsøen JB; Kvistad CE Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338644 [TBL] [Abstract][Full Text] [Related]
10. Transplantation of placenta-derived mesenchymal stem cells in the EAE mouse model of MS. Fisher-Shoval Y; Barhum Y; Sadan O; Yust-Katz S; Ben-Zur T; Lev N; Benkler C; Hod M; Melamed E; Offen D J Mol Neurosci; 2012 Sep; 48(1):176-84. PubMed ID: 22638856 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells as a treatment for multiple sclerosis: a focus on experimental animal studies. Lotfy A; Ali NS; Abdelgawad M; Salama M Rev Neurosci; 2020 Jan; 31(2):161-179. PubMed ID: 31605598 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of bone marrow-derived mesenchymal stem cell transplantation in a non-immune model of demyelination. El-Akabawy G; Rashed LA Ann Anat; 2015 Mar; 198():11-20. PubMed ID: 25660362 [TBL] [Abstract][Full Text] [Related]
14. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis. Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291 [TBL] [Abstract][Full Text] [Related]
17. Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice. Hou Y; Ryu CH; Park KY; Kim SM; Jeong CH; Jeun SS Stem Cell Res Ther; 2013 Jul; 4(4):77. PubMed ID: 23826999 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system. Salinas Tejedor L; Berner G; Jacobsen K; Gudi V; Jungwirth N; Hansmann F; Gingele S; Prajeeth CK; Baumgärtner W; Hoffmann A; Skripuletz T; Stangel M Brain Behav Immun; 2015 Nov; 50():155-165. PubMed ID: 26140734 [TBL] [Abstract][Full Text] [Related]
19. Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis. Darlington PJ; Boivin MN; Bar-Or A Expert Rev Neurother; 2011 Sep; 11(9):1295-303. PubMed ID: 21864075 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells and their derived exosomes in multiple sclerosis disease: from paper to practice. Hamidi SH; Etebar N; Rahimzadegan M; Zali A; Roodsari SR; Niknazar S Mol Cell Biochem; 2024 Jul; 479(7):1643-1671. PubMed ID: 38977625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]